Close
Achema middle east
swop processing & packaging

In Britain, The ABPI Sets Out A Clear Antimicrobial Goal

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Lonza Widens Cell and Gene Therapy Suite with New Products

Lonza widens cell and gene therapy suite by way...

No New Drug Submissions by the FDA With Shutdown in Place

The Food and Drug Administration (FDA), which is already...

How to Tell if Your Loved One is Developing an Addiction

Watching a loved one change in ways you do...

The Future of Balding Treatments: What’s New in 2025

Are you balding or thinning out on top? It...

The Association of the British Pharmaceutical Industry (ABPI) has reemphasized its message to the industry about the development of new antibiotics on the eve of World Antibiotic Awareness Week.

Antibiotic-resistant illnesses are thought to have caused 1.2 million deaths worldwide in 2019, while in England, over 90,000 people were admitted to hospitals in 2019–20. But the world’s supply of new antibiotics hasn’t been able to stop the problem from getting worse.

Additionally, a significant global challenge to contemporary medicine is being created by the development of drug-resistant microorganisms more quickly than new antimicrobial therapies.

The goal of World Antibiotic Awareness Week this year is to increase awareness and understanding of antimicrobial resistance (AMR). Better behaviour among the general public, healthcare professionals, and policymakers will be promoted by the event in an effort to stop the antibiotic resistance from spreading. The core pillars of contemporary medicine are under threat from antibiotic resistance, according to Amit Aggarwal, executive director of medical affairs at the ABPI. The use and administration of these essential medications by individual healthcare professionals and patients will make a significant contribution to the worldwide effort needed to overcome the dilemma.

The UK is already playing a pioneering role in combating resistance to antibiotics through reforms to how it rewards and incentivizes antibiotic research, but it will not win this battle by itself, he continued. The advancement of new antimicrobial therapies must be given top priority while they continue to encourage global efforts to enhance the way they employ currently available antibiotics.

Antibiotic resistance happens when the bacteria that causes an infection cannot be treated with the antimicrobial medications that are currently accessible.

 Every healthcare system in the world depends on the usage of antibiotics for routine medical procedures like tooth extractions, chemotherapy, sepsis, and surgery.

Latest stories

Related stories

Lonza Widens Cell and Gene Therapy Suite with New Products

Lonza widens cell and gene therapy suite by way...

No New Drug Submissions by the FDA With Shutdown in Place

The Food and Drug Administration (FDA), which is already...

How to Tell if Your Loved One is Developing an Addiction

Watching a loved one change in ways you do...

The Future of Balding Treatments: What’s New in 2025

Are you balding or thinning out on top? It...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »